While the Apple Watch has become a bigger and bigger success for Apple over the years, one major reason for that is how much it has helped keep people safe and aware of any heart irregularities. Users will get a notification letting them know that they had an irregular heart rhythm, which could lead to something severe and knowing about it ASAP can save lives.
However, Apple isn’t content to stop where it currently is in the heart health category, and has announced they are working on a new study with Johnson & Johnson that will gather more information about atrial fibrillation and other conditions. This new Heartline Study will include a new iPhone app, and will see if health tracking on iPhone and heart tracking on Apple Watch can improve health outcomes.
Myoung Cha, Apple’s Head of Health Strategic Initiatives, said the following:
“Apple technology is making a meaningful impact on scientific research through the powerful capabilities of iPhone and Apple Watch, all with privacy at the center of the participant experience. The Heartline Study will help further understanding of how our technology could both contribute to science and help improve health outcomes, including reducing the risk of stroke.”
If you are interested in the study, you must be 65 or older, a U.S. resident for the duration of the study, have traditional Medicare, own an iPhone 6S or later (with iOS 12.2 or later installed), and agree to provide access to your Medicare claims data. Participants will be selected at random and then divided into two groups: one only using the iPhone app and the other will use the iPhone app in addition to obtaining an Apple Watch. The study is expected to last three years.